Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP417877.RA_j1VLZBm7RJx_farPx7Z-outocgqeszRLrCZe_wSMdY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP417877.RA_j1VLZBm7RJx_farPx7Z-outocgqeszRLrCZe_wSMdY130_assertion type Assertion NP417877.RA_j1VLZBm7RJx_farPx7Z-outocgqeszRLrCZe_wSMdY130_head.
- NP417877.RA_j1VLZBm7RJx_farPx7Z-outocgqeszRLrCZe_wSMdY130_assertion description "[The low expression of GalNAc-T3 may be a useful marker for predicting poor prognosis and early recurrence in completely resected lung carcinoma patients, particularly patients with stage I diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP417877.RA_j1VLZBm7RJx_farPx7Z-outocgqeszRLrCZe_wSMdY130_provenance.
- NP417877.RA_j1VLZBm7RJx_farPx7Z-outocgqeszRLrCZe_wSMdY130_assertion evidence source_evidence_literature NP417877.RA_j1VLZBm7RJx_farPx7Z-outocgqeszRLrCZe_wSMdY130_provenance.
- NP417877.RA_j1VLZBm7RJx_farPx7Z-outocgqeszRLrCZe_wSMdY130_assertion SIO_000772 14735190 NP417877.RA_j1VLZBm7RJx_farPx7Z-outocgqeszRLrCZe_wSMdY130_provenance.
- NP417877.RA_j1VLZBm7RJx_farPx7Z-outocgqeszRLrCZe_wSMdY130_assertion wasDerivedFrom befree-20150227 NP417877.RA_j1VLZBm7RJx_farPx7Z-outocgqeszRLrCZe_wSMdY130_provenance.
- NP417877.RA_j1VLZBm7RJx_farPx7Z-outocgqeszRLrCZe_wSMdY130_assertion wasGeneratedBy ECO_0000203 NP417877.RA_j1VLZBm7RJx_farPx7Z-outocgqeszRLrCZe_wSMdY130_provenance.